Intrarosa

Discussion in 'AMAG Pharmaceuticals' started by anonymous, Feb 17, 2017 at 10:27 AM.

Tags: Edit
  1. anonymous

    anonymous Guest

    Hey phucktard, I knew you were going to hire the Teva girl. Oh wow what a surprise. Boy you sure had a douch bag look on your face when I called you out on it! It's good to be from Teva. Thanks for wasting my time
     

  2. anonymous

    anonymous Guest

    Two words...weed brownie.
     
  3. anonymous

    anonymous Guest

    If you don't mind me asking what territory in the Northeast? I know they were having issues because there is no manager yet.
     
  4. anonymous

    anonymous Guest

    I give this sales force 9 months before panic sets in and talk of laying off begins or layoffs occur. Save those paychecks.
     
  5. anonymous

    anonymous Guest


    Is this post by someone who just completed training or someone who didn't get the job?
     
  6. anonymous

    anonymous Guest

    Anyone that took the job just wants the paycheck. The pay is decent for the drug being promoted, but the drug will not make it. Time will prove it.
     
  7. anonymous

    anonymous Guest

    You need to move on.
     
  8. anonymous

    anonymous Guest

    I agree with the above poster. Osphena was a dog and this will be too.
     
  9. anonymous

    anonymous Guest

    There has been a negative poster all along. My guess is someone who was turned down.
     
  10. anonymous

    anonymous Guest

    my guess is poster is one and the same
     
  11. anonymous

    anonymous Guest

    To make everyone feel better, this poster will fade away and let the feel good vibes flow. Happy product launch! I will revisit you guys in January to say I told you so.
     
  12. anonymous

    anonymous Guest

    just got initial call from recruiter for So Cal position, will have phone screen tomorrow. Seems like West Coast is way behind in the process? Thanks to everyone who has provided actual information. Please keep the helpful info coming.
     
  13. anonymous

    anonymous Guest

     
  14. anonymous

    anonymous Guest

    this product will be impossible to sell since the audience for the drug is the Medicare patient. By the time Medicare coverage is approved the sales force will be long gone. Anyway, what MCO would pay for a drug that is OTC?
     
  15. anonymous

    anonymous Guest

    this product will be impossible to sell since the audience for the drug is the Medicare patient. By the time Medicare coverage is approved the sales force will be long gone. Anyway, what MCO would pay for a drug that is OTC?
     
  16. anonymous

    anonymous Guest

    If they do major layoffs by Christmas, let's all just hope they don't keep Kapeller and the sleezy, degenerate managers they should be booting.
     
  17. anonymous

    anonymous Guest

    Most recognized OB/GYNs already underwhelmed with Intrarosa as option. Damn! This is going to be a loser!
     
  18. anonymous

    anonymous Guest

    If you needed anyone to tell you this, you have no business selling in women's health. No one should be surprised. This drug was dead on arrival before it was approved. At least the company was dumb enough to pay decent salaries for a little while. Many took one look at the drug and passed. Keep that resume circulating.
     
  19. anonymous

    anonymous Guest

    Agree 100% Anyone who looks at the pi and clinical studies can discern right away there's no need for it. Other affordable treatment options are out there for this indication "and" more! The efficacy for Intrarosa is so-so at best. Not a good drug! No compelling reason to even write it except after everything else has failed, and at that point it's still unlikely to benefit anyone.

    Why doesn't AMAG do right thing for once, and immediately lay-off managers? The majority I've met are worthless, making a crap drug, even harder to sell.
     
  20. anonymous

    anonymous Guest

    1 of area's top volume ob/gyn told me today he had 3 questions 1) intrarosa only had indication for dyspareunia, so why should he use it at all when majority of patients have other symptoms with VVA and there are well established options that treat dyspareunia and other symptoms? 2) Why does our co-pay state patients may pay no more than $25.00/month when competing product proven very effective is $20 or nothing/per month? Our studies are not that great! This launch is an embarrassment! Paying for wall street marketing doesn't work in the long run to persuade doctors in the long run. Stupid, stupid, stupid! I'm embarrassed for other good reps working for idiots. What did I sign onto?